The phase-I human clinical trial of India's first indigenously-developed vaccine against novel coronavirus, Covaxin, began at Delhi AIIMS on Friday and the first dose of the injection was...

from NDTV News - Topstories https://ift.tt/3eZbY7z
https://ift.tt/eA8V8J